Clinical Trial Update: Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating dose adjustments for kidney transplant patients using immediate-release and extended-release tacrolimus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Failure

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Sentara Norfolk General Hospital | Conditions: Transplant;Failure,Kidney | Phase 4 | Status: COMPLETED